Search | Clinical Trials Finder

ClinicalTrials.gov public records Last synced Sep 12, 2026, 12:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–15 of 15 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: HIV-associated Neuropathy Clear all

Conditions: HIV Infections, Peripheral Neuropathy
Interventions: pregabalin, Placebo; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 41
States / cities: Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 29 more

Conditions: HIV Associated Polyneuropathy
Interventions: WST-057, Placebo; Drug
Lead sponsor: WinSanTor, Inc; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Palm Springs, California • San Diego, California

Conditions: HIV-associated Neuropathy, Polyneuropathy
Interventions: SAB378, methadone, SAB placebo, Methadone placebo; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 3
States / cities: San Diego, California • Brooklyn, New York • Rochester, New York

Conditions: Peripheral Neuropathy, HIV Infections
Interventions: pregabalin; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 34
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 24 more

Conditions: HIV Infections, Peripheral Nervous System Diseases
Interventions: Acetyl-L-carnitine; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2007
U.S. locations: 10
States / cities: Palo Alto, California • Atlanta, Georgia • Honolulu, Hawaii + 5 more

Conditions: HIV Infections, Peripheral Nervous System Diseases, Pain
Interventions: Capsaicin Dermal Patch; Drug
Lead sponsor: NeurogesX; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 2
States / cities: Sarasota, Florida • Annandale, Virginia

Conditions: HIV Infections
Interventions: Capsaicin Dermal Patch; Drug
Lead sponsor: NeurogesX; Industry
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 3
States / cities: West Hollywood, California • New York, New York • Portland, Oregon

Conditions: Neuropathy
Interventions: pregabalin, placebo; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 377 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 25
States / cities: Phoenix, Arizona • Los Angeles, California • North Hollywood, California + 15 more

Conditions: HIV, AIDS, Peripheral Neuropathy, Pain, Sleep
Interventions: Splinting application to the lower extremities, Splint liner application; Device
Lead sponsor: Texas Woman's University; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: HIV Infections, Peripheral Nervous System Disease
Interventions: Nerve Growth Factor, Recombinant Human; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 1999
U.S. locations: 14
States / cities: Los Angeles, California • San Mateo, California • Stanford, California + 10 more

Conditions: HIV, Non-HIV, Vagus Nerve Dysfunction
Interventions: Pyridostigmine, Placebos, non-invasive vagal nerve stimulation; Drug · Procedure
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 215 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: HIV-1 Infection, Neuropathic Pain
Interventions: pregabalin (Lyrica); Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 217 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 10
States / cities: Phoenix, Arizona • Burbank, California • Palm Springs, California + 4 more

Conditions: HIV Infections, Peripheral Nervous System Diseases, Pain
Interventions: Capsaicin Dermal Patch; Drug
Lead sponsor: NeurogesX; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 35
States / cities: Phoenix, Arizona • Berkeley, California • San Diego, California + 29 more

Conditions: Neuropathic Pain, Distal Sensory Polyneuropathy
Interventions: LY3848575, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 558 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 24
States / cities: Chandler, Arizona • Phoenix, Arizona • Fresno, California + 20 more

Conditions: HIV Infections, Peripheral Neuropathy
Interventions: Duloxetine, Duloxetine placebo, Methadone, Methadone placebo; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 8
States / cities: San Diego, California • Torrance, California • Aurora, Colorado + 5 more

Search by objective public record fields.

Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy

A 16-Week Study of Pirenzepine or Placebo to Treat HIV-Associated Distal Sensory Polyneuropathy in Patients With HIV

Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy

Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy

Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy

Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy

Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy

Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy

Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy

A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy

Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

Pregabalin Trial In HIV Neuropathic Pain

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

Combination Pain Therapy in HIV Neuropathy